Zacks Investment Research on MSN1 小时
PCRX Doses First Patient in Phase II PCRX-201 Gene Therapy Study
Pacira BioSciences PCRX announced that it has dosed the first patient in a mid-stage study of pipeline candidate PCRX-201 ...